Nearshore Protein reported revenue of 1.46 billion yuan in 2025, an increase of 14.80%. Gross margin rose to 67.11%, but net loss attributable to shareholders amounted to 77.7834 million yuan.

In 2025, the company's revenue increased by 14.80% year-on-year to RMB 146 million, with the gross margin improving to 67.11%. However, the net loss attributable to shareholders widened to RMB -77.7834 million, and the net profit margin deteriorated to -53.12%. Operating cash flow turned negative, mainly dragged down by high investments in R&D and sales, reduced government subsidies, and an increase in deferred income tax. Technical certification capabilities continued to strengthen, but industrialization implementation lagged, overseas expansion remained weak, and the efficiency of profitability conversion was low.

lanjinger.comApr 29 15:40

Nearshore Protein: Summary of the 2025 Annual Report

SZSIApr 29 00:00 · Announcements

Nearshore Protein: First Quarter Report for 2026

SZSIApr 29 00:00 · Announcements

Nearshore Protein: 2025 Annual Report

SZSIApr 29 00:00 · Announcements

Annual Report 2025

SZSIApr 29 00:00 · Announcements

Summary of the 2025 Annual Report

SZSIApr 29 00:00 · Announcements